| Acute-phase proteins and other systemic responses to inflammation C Gabay, I Kushner New England journal of medicine 340 (6), 448-454, 1999 | 9186 | 1999 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update JS Smolen, R Landewé, J Bijlsma, G Burmester, K Chatzidionysiou, ... Annals of the rheumatic diseases 76 (6), 960-977, 2017 | 3199 | 2017 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs JS Smolen, R Landewé, FC Breedveld, M Dougados, P Emery, ... Annals of the rheumatic diseases 69 (6), 964-975, 2010 | 2448 | 2010 |
| Interleukin-6 and chronic inflammation C Gabay Arthritis research & therapy 8, 1-6, 2006 | 2007 | 2006 |
| Interleukin-1 receptor antagonist: role in biology WP Arend, M Malyak, CJ Guthridge, C Gabay Annual review of immunology 16 (1), 27-55, 1998 | 1450 | 1998 |
| IL‐1, IL‐18, and IL‐33 families of cytokines WP Arend, G Palmer, C Gabay Immunological reviews 223 (1), 20-38, 2008 | 1123 | 2008 |
| IL-1 pathways in inflammation and human diseases C Gabay, C Lamacchia, G Palmer Nature Reviews Rheumatology 6 (4), 232-241, 2010 | 1092 | 2010 |
| Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial C Gabay, P Emery, R Van Vollenhoven, A Dikranian, R Alten, K Pavelka, ... The Lancet 381 (9877), 1541-1550, 2013 | 853 | 2013 |
| EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis DM Gerlag, K Raza, LGM Van Baarsen, E Brouwer, CD Buckley, ... Annals of the rheumatic diseases 71 (5), 638-641, 2012 | 550 | 2012 |
| The interleukin (IL)-1 cytokine family–Balance between agonists and antagonists in inflammatory diseases J Palomo, D Dietrich, P Martin, G Palmer, C Gabay Cytokine 76 (1), 25-37, 2015 | 543 | 2015 |
| Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. C Gabay, MF Smith, D Eidlen, WP Arend The Journal of clinical investigation 99 (12), 2930-2940, 1997 | 451 | 1997 |
| Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis N Busso, A So, V Chobaz-Péclat, C Morard, E Martinez-Soria, ... The Journal of Immunology 168 (2), 875-882, 2002 | 440 | 2002 |
| Prevotella copri in individuals at risk for rheumatoid arthritis D Alpizar-Rodriguez, TR Lesker, A Gronow, B Gilbert, E Raemy, ... Annals of the rheumatic diseases 78 (5), 590-593, 2019 | 420 | 2019 |
| Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells D Moulin, O Donzé, D Talabot-Ayer, F Mézin, G Palmer, C Gabay Cytokine 40 (3), 216-225, 2007 | 411 | 2007 |
| Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis G Palmer, D Talabot‐Ayer, C Lamacchia, D Toy, CA Seemayer, S Viatte, ... Arthritis & rheumatism: official journal of the American College of …, 2009 | 408 | 2009 |
| Leptin deficiency enhances sensitivity to endotoxin-induced lethality R Faggioni, G Fantuzzi, C Gabay, A Moser, CA Dinarello, KR Feingold, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 1999 | 406 | 1999 |
| Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics G Dennis, CTJ Holweg, SK Kummerfeld, DF Choy, AF Setiadi, ... Arthritis research & therapy 16, 1-18, 2014 | 394 | 2014 |
| Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome ES Weiss, C Girard-Guyonvarc’h, D Holzinger, AA de Jesus, Z Tariq, ... Blood, The Journal of the American Society of Hematology 131 (13), 1442-1455, 2018 | 385 | 2018 |
| IL-36R ligands are potent regulators of dendritic and T cells S Vigne, G Palmer, C Lamacchia, P Martin, D Talabot-Ayer, E Rodriguez, ... Blood, The Journal of the American Society of Hematology 118 (22), 5813-5823, 2011 | 384 | 2011 |
| IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? CA Meier, E Bobbioni, C Gabay, F Assimacopoulos-Jeannet, A Golay, ... The Journal of Clinical Endocrinology & Metabolism 87 (3), 1184-1188, 2002 | 379 | 2002 |
